secwatch / observer

Earnings Releases

Quarterly and annual results disclosed under 8-K Item 2.02.

8-K items 2.02 JSON
DBD DIEBOLD NIXDORF, Inc

DIEBOLD NIXDORF, Inc reported financial results for first quarter of 2024.

“On May 2, 2024, Diebold Nixdorf, Incorporated (the “Company”) issued a news release announcing its results for the first quarter of 2024 (the "News Release").”
CW CURTISS WRIGHT CORP

CURTISS WRIGHT CORP reported first quarter ended March 31, 2024 results: revenue $713 million, EPS $1.99. Guidance raised.

“– May 1, 2024 – Curtiss-Wright Corporation (NYSE: CW) reports financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights: • Reported sales of $713 million, up 13%, operating income of $100 million, up 27%, operating margin of 14.0%, and diluted earnings per share (EPS) of $1.99; • Adjusted operating income of $100 million, up 23%;”
CMI CUMMINS INC

CUMMINS INC reported the first quarter of 2024 results: revenue $8.4 billion, net income $2.0 billion, EPS $14.03 per diluted share. Guidance raised.

“of the Company under the Securities Act of 1933 or the Exchange Act. --- EX-99 (EX-99) --- May 2, 2024 Cummins Reports First Quarter 2024 Results • First quarter revenues of $8.4 billion; GAAP 1 Net Income of $2.0 billion • EBITDA in the first quarter was 30.6% of sales; Diluted EPS of $14.03 • First quarter results include a net gain of $1.3 billion, or $9.08”
CTO CTO Realty Growth, Inc.

CTO Realty Growth, Inc. reported the quarter ended March 31, 2024 results: net income $4,655, EPS $0.20. Guidance raised.

“Reported Net Income per diluted share attributable to common stockholders of $0.20 for the quarter ended March 31, 2024.”
ITT ITT INC.

ITT INC. reported first quarter ended March 30, 2024 results: revenue $910.6, EPS $1.34. Guidance raised.

“compensation payments. Free cash flow for the quarter of $30 million increased $1 million versus prior year. 1 Table 1. First Quarter Performance Q1 2024 Q1 2023 Change Revenue $ 910.6 $ 797.9 14.1 % Organic Growth 9.5 % Operating Income $ 149.2 $ 124.3 20.0 % Operating Margin 16.4 % 15.6 % 80 bps Adjusted Operating Income $ 155.0 $ 126.2 22.8 % Adjusted”
COHU COHU INC

COHU INC reported first fiscal quarter ended March 30, 2024 results: revenue $107.6 million, net income $14.6 million or $0.31 per share, EPS $0.31 per share.

“made by Cohu wit --- EX-99.1 (EXHIBIT 99.1) --- EX-99.1 2 ex_664873.htm EXHIBIT 99.1 ex_664873.htm Exhibit 99.1 Cohu Reports First Quarter 2024 Results ● First quarter revenue $107.6 million, approximately 66% recurring ● Gross margin of 45.8%; non-GAAP gross margin of 46.0% ● Sense+ system with μ -sense selected for testing next-generation high fidelity microphones”
VSTS Vestis Corp

Vestis Corp updated its the quarter ended March 29, 2024 guidance (lowered).

“On May 2, 2024 , Vestis Corporation (the “Company”) issued a press release announcing the results of the Company’s operations for the quarter ended March 29, 2024.”
Kimco Realty OP, LLC

Kimco Realty OP, LLC reported first quarter ended March 31, 2024 results: net income ($18.9) million, EPS ($0.03) per diluted share.

“On May 2, 2024, Kimco Realty Corporation (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2024.”
ZYME Zymeworks Inc.

Zymeworks Inc. reported three months ended March 31, 2024 results: revenue $10.0 million.

“Revenue was $10.0 million for the three months ended March 31, 2024 compared to $35.6 million for the same period in 2023.”
RXO RXO, Inc.

RXO, Inc. reported the first quarter of 2024 results: net income GAAP net loss of $15 million, EPS GAAP diluted loss per share of $0.13. Guidance initiated.

“The company reported a first-quarter 2024 GAAP net loss of $15 million, compared to $0 of net income in the first quarter of 2023. The first-quarter 2024 GAAP net loss included $12 million in transaction, integration and restructuring costs. The adjusted net loss in the quarter was $4 million, compared to adjusted net income of $13 million in the first quarter of 2023. Adjusted EBITDA was $15 million, compared to $37 million in the first quarter of 2023. Adjusted EBITDA margin was 1.6%, compared to 3.7% in the first quarter of 2023. Transaction, integration and restructuring costs, and amortization of intangibles, impacted GAAP earnings per share by $0.10, net of tax. For the first quarter, RXO reported a GAAP diluted loss per share of $0.13.”
Federal Realty OP LP

Federal Realty OP LP reported financial results for the quarter ended March 31, 2024.

“On May 2, 2024, Federal Realty Investment Trust issued supplemental data pertaining to its operations, as well as a press release, to report its financial results for the quarter ended March 31, 2024.”
DKNG DraftKings Inc.

DraftKings Inc. reported the quarter ended March 31, 2024 results: revenue $1,175 million. Guidance raised.

“as amended, except as shall be expressly set forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- DraftKings Reports First Quarter Revenue Growth of 53% to $1,175 million; Raises 2024 Revenue Guidance Midpoint to $4.9 Billion and 2024 Adjusted EBITDA Guidance Midpoint to $500 Million Boston, MA – May 2, 2024 — DraftKings Inc. (Nasdaq: DKNG)”
OLPX OLAPLEX HOLDINGS, INC.

OLAPLEX HOLDINGS, INC. updated its first quarter ended March 31, 2024 guidance (reaffirmed).

“On May 2, 2024, Olaplex Holdings, Inc. (the “Company”) issued a press release announcing its results of operations for the first quarter ended March 31, 2024.”
SWAG Stran & Company, Inc.

Stran & Company, Inc. reported financial results for the fiscal quarter ended March 31, 2024.

“On May 2, 2024, Stran & Company, Inc. (the “Company”) issued a press release announcing that the Company will hold a conference call at 10:00 A.M. Eastern Time on Wednesday, May 15, 2024, to discuss its financial results for the fiscal quarter ended March 31, 2024”
BTSG BrightSpring Health Services, Inc.

BrightSpring Health Services, Inc. reported first quarter ended March 31, 2024 results: revenue $2,577 million, net income Net loss of $46 million. Guidance raised.

“today announced financial results for the first quarter ended March 31, 2024, and increases 2024 revenue and Adjusted EBITDA 1 guidance. Financial Highlights • Net Revenue of $2,577 million, up 27.0% compared to $2,028 million in the first quarter of 2023. • Net loss of $46 million, compared to net loss of $22 million in the first quarter of 2023. • Adjusted EBITDA”
Stronghold Digital Mining, Inc.

Stronghold Digital Mining, Inc. reported the first quarter ended March 31, 2024 results: revenue $27.5 million, net income $5.8 million.

“Stronghold Digital Mining, Inc. ( NASDAQ: SDIG) (“Stronghold”, the “Company”, or “we”) today announced financial and operational results for the first quarter of 2024 and provided other strategic updates: Recent Financial Highlights • The Company generated revenues of $27.5 million during the first quarter of 2024, up 27% sequentially and 59% year-over-year. Revenues comprised $26.7 million from cryptocurrency operations, $0.7 million from the sale of energy, and $0.1 million from other activities. • First quarter 2024 fixed costs were down 3% sequentially and 11% year-over-year, demonstrating Stronghold’s operating leverage and cost controls. Fixed costs include operations & maintenance expenses and general & administrative expenses, excluding stock-based compensation. • The Company earned GAAP Net Income of $5.8 million and non-GAAP Adjusted EBITDA of $8.7 million during the first quarter of 2024.”
APO Apollo Global Management, Inc.

Apollo Global Management, Inc. reported financial results for first quarter ended March 31, 2024.

“On May 2, 2024, Apollo Global Management, Inc. ("Apollo") issued a summary press release and a detailed earnings presentation announcing its financial results for the first quarter ended March 31, 2024.”
CLST Catalyst Bancorp, Inc.

Catalyst Bancorp, Inc. reported first quarter of 2024 results: net income net loss of $4.7 million.

“Catalyst Bancorp, Inc. (Nasdaq: “CLST”) (the “Company”), the parent company for Catalyst Bank (the “Bank”) (www.catalystbank.com), reported a net loss of $4.7 million for the first quarter of 2024”
RYAN RYAN SPECIALTY HOLDINGS, INC.

RYAN SPECIALTY HOLDINGS, INC. reported first quarter ended March 31, 2024 results: revenue $552.0 million, net income $40.7 million, EPS $0.13 per diluted share.

“RYAN SPECIALTY REPORTS FIRST QUARTER 2024 RESULTS - Total Revenue grew 20.6% year-over-year to $552.0 million - - Organic Revenue Growth Rate* of 13.7% year-over-year 1 - - Net Income of $40.7 million, or $0.13 per diluted share”
APA APA Corp

APA Corp reported first quarter of 2024 results: net income net income attributable to common stock of $132 million, EPS $0.44 per diluted share. Guidance reaffirmed.

“APA reported net income attributable to common stock of $132 million, or $0.44 per diluted share. When adjusted for items that impact the comparability of results, APA’s first-quarter earnings were $237 million, or $0.78 per diluted share.”
BMEA Biomea Fusion, Inc.

Biomea Fusion, Inc. reported financial results for the quarter ended March 31, 2024.

“On May 2, 2024, Biomea Fusion, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2024.”
AdTheorent Holding Company, Inc.

AdTheorent Holding Company, Inc. reported first quarter ended March 31, 2024 results: revenue Revenue was $34.9 million, net income Net loss was $9.9 million.

“First Quarter 2024 Financial Overview: • Revenue was $34.9 million, a 6.7% increase compared to $32.7 million in the first quarter of 2023.”
BBAI BigBear.ai Holdings, Inc.

BigBear.ai Holdings, Inc. reported the first quarter of 2024 results: revenue $33.1 million, net income $125.1 million. Guidance reaffirmed.

“autonomy at the edge, contested logistics, modeling & simulation, and digital identity for our customers,” she continued. Financial Highlights • Revenue decreased 21.4% to $33.1 million for the first quarter of 2024, compared to $42.2 million for the first quarter of 2023. The year-over-year decrease was primarily driven by the planned wind-down of the Air Force”
HAYW Hayward Holdings, Inc.

Hayward Holdings, Inc. reported first quarter ended March 30, 2024 of its fiscal year 2024 results: revenue $212.6 million, net income $9.8 million, EPS $0.04. Guidance reaffirmed.

“filing. --- EX-99.1 (EX-99.1) --- May 2, 2024 Hayward Holdings Announces First Quarter Fiscal Year 2024 Financial Results FIRST QUARTER FISCAL 2024 SUMMARY • Net Sales of $212.6 million • Net Income of $9.8 million • Adjusted EBITDA* of $45.0 million • Diluted EPS of $0.04 and adjusted diluted EPS* of $0.08 CHARLOTTE, N.C. -- (BUSINESS WIRE) -- Hayward Holdings,”
ALHC Alignment Healthcare, Inc.

Alignment Healthcare, Inc. reported first quarter ended March 31, 2024 results: revenue $628.6 million, net income $(46.6) million. Guidance raised.

“in such filing. --- EX-99.1 (PRESS RELEASE) --- EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Alignment Healthcare Reports First Quarter 2024 Results Reports $628.6 million in total revenue and $627.6 million in revenue excluding ACO REACH, up 43.1% and 54.2% y ear-over-year respectively Medicare Advantage membership grows 50.5% year-over-year to”
Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc. reported financial results for first quarter 2024.

“On May 2, 2024, Longboard Pharmaceuticals, Inc. ("Longboard") issued a press release announcing its financial results for the quarter ended March 31, 2024.”
HIPO Hippo Holdings Inc.

Hippo Holdings Inc. reported the quarter ended March 31, 2024 results: revenue $85 million, net income $36 million.

“with Services and Insurance-as-a-Service (“IaaS”) representing 80% of TGP • Services and IaaS driving TGP growth, up 37% and 25% YoY, respectively in Q1 • Revenue up 114% YoY to $85 million; significantly better Revenue monetization in Hippo Home Insurance Program (“HHIP") Continued HHIP Loss Ratio Improvement • HHIP Q1 gross loss ratio improved 21pp YoY to 80% • Q1”
DFH Dream Finders Homes, Inc.

Dream Finders Homes, Inc. reported first quarter ended March 31, 2024 results: revenue $825 million, net income $54 million, EPS $0.55 per basic share.

“Securities Act of 1933, as amended, or the Exchange Act. --- EX-99.1 (EX-99.1) --- Dream Finders Announces First Quarter 2024 Results First Quarter Homebuilding Revenues of $825 million Net New Orders Up 19% , Net Income to DFH Up 11% Return on Participating Equity of 34.9% Jacksonville, FL. — May 2, 2024 — Dream Finders Homes, Inc. (the “Company”, “Dream”
OWL BLUE OWL CAPITAL INC.

BLUE OWL CAPITAL INC. reported financial results for the quarter ended March 31, 2024.

“On May 2, 2024, Blue Owl Capital Inc. (the “Company”) reported its financial results for the quarter ended March 31, 2024.”
SHC Sotera Health Co

Sotera Health Co reported three months ended March 31, 2024 results: revenue $248 million, net income $6 million, or $0.02 per diluted share, EPS $0.02 per diluted share. Guidance reaffirmed.

“incorporated by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Sotera Health Reports First-Quarter 2024 Results • Q1 2024 net revenues increased 12.5% to $248 million, compared to Q1 2023 • Q1 2024 net income of $6 million or $0.02 per diluted share, comp ared to net income of $3 million or $0.01 per diluted share in Q1 2023 • Q1 2024 Adjusted”
OGN Organon & Co.

Organon & Co. reported the first quarter ended March 31, 2024 results: revenue $1,622 million, net income $201 million, EPS $0.78. Guidance reaffirmed.

“First quarter 2024 revenue of $1,622 million, up 5% on an as-reported basis and 7% at constant currency • First quarter 2024 diluted earnings per share of $0.78 and non-GAAP Adjusted diluted earnings per share of $1.22; both reported and non-GAAP Adjusted diluted earnings per share include $15 million expense, or $(0.05) per share, for acquired in-process research and development (IPR&D) and milestones • First quarter 2024 net income of $201 million and Adjusted EBITDA (non-GAAP) of $538 million • Full year 2024 financial guidance ranges affirmed”
SHC Sotera Health Co

Sotera Health Co reported the three months ended March 31, 2024 results: revenue $248 million, net income $6 million, EPS $0.02 per diluted share. Guidance reaffirmed.

“First-quarter 2024 net revenues increased 12.5% to $248 million, compared to $221 million in the first-quarter 2023.”
SES SES AI Corp

SES AI Corp reported financial results for the fiscal quarter ended March 31, 2024.

“On May 2, 2024, SES AI Corporation (the “Company”) released a letter to its shareholders, which includes a business update and the Company’s financial results for the fiscal quarter ended March 31, 2024.”
DYN Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc. reported the quarter ended March 31, 2024 results: net income $65.6 million, or $0.81 per basic and diluted share, EPS $0.81 per basic and diluted share.

“Net loss for the quarter ended March 31, 2024 was $65.6 million, or $0.81 per basic and diluted share.”
KYMR Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc. reported financial results for the quarter ended March 31, 2024.

“On May 2, 2024, Kymera Therapeutics, Inc. announced its financial results for the quarter ended March 31, 2024.”
RLAY Relay Therapeutics, Inc.

Relay Therapeutics, Inc. reported first quarter 2024 results: revenue $10.0 million, net income $81.4 million, EPS $0.62.

“The company expects its current cash, cash equivalents and investments will be sufficient to fund its current operating plan into the second half of 2026. Revenue: Revenue was $10.0 million for the first quarter of 2024, as compared to $0.2 million for the first quarter of 2023. The increase was primarily due to a payment of $10.0 million in connection with a”
DRVN Driven Brands Holdings Inc.

Driven Brands Holdings Inc. reported the first quarter ending March 30, 2024 results: revenue $572 million, net income $4.3 million or $0.03 per diluted share, EPS $0.03 per diluted share. Guidance reaffirmed.

“DRVN) (“Driven Brands” or the “Company”) today reported financial results for the first quarter ending March 30, 2024. For the first quarter, Driven Brands delivered revenue of $572 million, up 2% versus the prior year. System-wide sales were $1.6 billion, up 7% versus the prior year primarily driven by 0.7% same store sales growth and 144 net new units. Net Income”
RKT Rocket Companies, Inc.

Rocket Companies, Inc. reported Q1'24 results: revenue $1.4 billion, net income $291 million, EPS $0.11 per GAAP diluted earnings per share.

“Generated Q1'24 total revenue, net of $1.4 billion and adjusted revenue of $1.2 billion. Adjusted revenue exceeded the high end of guidance range, and year-over-year growth accelerated for the third quarter in a row • Reported Q1'24 GAAP net income of $291 million, or $0.11 per GAAP diluted earnings per share and adjusted net income of $84 million, or $0.04 per adjusted diluted earnings per share • Delivered Q1'24 adjusted EBITDA of $174 million, the highest adjusted EBITDA in two years”
RKT Rocket Companies, Inc.

Rocket Companies, Inc. reported first quarter ended March 31, 2024 results: revenue $1,384, net income $291 million, EPS $0.11 per GAAP diluted earnings per share.

“our mission to help everyone home.” First Quarter 2024 Financial Summary 1 ROCKET COMPANIES ($ in millions, except per share amounts) Q1-24 Q1-23 (Unaudited) Total revenue, net $ 1,384 $ 666 Total expenses $ 1,085 $ 1,082 GAAP net income (loss) $ 291 $ (411) Adjusted revenue $ 1,163 $ 882 Adjusted net income (loss) $ 84 $ (111) Adjusted EBITDA $ 174 $ (79) GAAP”
MP MP Materials Corp. / DE

MP Materials Corp. / DE reported three months ended March 31, 2024 results: revenue $48,684, net income $16,489, EPS $(0.08).

“Highlights For the three months ended March 31, 2024 vs. 2023 (unaudited) 2024 2023 Amount Change % Change Financial Measures: (in thousands, except per share data) Revenue (1) $ 48,684 $ 95,700 $ (47,016) (49) % Net income $ 16,489 $ 37,447 $ (20,958) (56) % Adjusted EBITDA (2) $ (1,233) $ 58,700 $ (59,933) N/M Adjusted Net Income (Loss) (2) $ (7,492) $ 51,327 $”
XPOF Xponential Fitness, Inc.

Xponential Fitness, Inc. reported first quarter ended March 31, 2024 results: revenue $79.5 million, net income net loss of $4.4 million, or a loss of $0.30 per basic share, EPS loss of $0.30 per basic share. Guidance reaffirmed.

“reconciliation to the corresponding GAAP measures are included in the tables that accompany this release. Financial Highlights: Q1 2024 Compared to Q1 2023 • Grew revenue 12% to $79.5 million. • Increased North America system-wide sales 1 by 25% to $401.1 million. • Reported North America same store sales 2 growth of 9%, compared to growth of 19%. • Reported North”
OPEN Opendoor Technologies Inc.

Opendoor Technologies Inc. reported the first quarter ended March 31, 2024 results: revenue $1.2 billion, net income $(109) million.

“the future of real estate, empowering consumers to sell and buy with ease through a simple, certain, and transparent offering.” First Quarter 2024 Key Highlights • Revenue of $1.2 billion, down (62)% versus 1Q23 and up 36% versus 4Q23; with 3,078 total homes sold, down (63)% versus 1Q23 and up 30% versus 4Q23 • Gross profit of $114 million, versus $170 million in”
Dun & Bradstreet Holdings, Inc.

Dun & Bradstreet Holdings, Inc. reported financial results for first quarter of 2024.

“On May 2, 2024, Dun & Bradstreet Holdings, Inc. (“Dun & Bradstreet” or the “Company”) issued a press release announcing its financial results for the first quarter of 2024.”
APG APi Group Corp

APi Group Corp reported the three months ended March 31, 2024 results: revenue $1,601, net income $45 million, EPS $(1.34).

“First Quarter 2024 Consolidated Results: Three Months Ended March 31, 2024 2023 Y/Y Y/Y (FFX) (a) Net revenues $ 1,601 $ 1,614 (0.8) % (1.2) % Organic net revenue growth (b) (1.4) % GAAP Gross profit $ 492 $ 425 15.8 % Gross margin 30.7 % 26.3 % + 440 bps Net income $ 45 $ 26 73.1 % Diluted EPS $ (1.34) $ 0.05 NM”
VNT Vontier Corp

Vontier Corp reported the first quarter ended March 29, 2024 results: revenue $755.8 million, net income $136.8 million, EPS $0.88. Guidance reaffirmed.

“Mobility strategy, coupled with a comprehensive suite of industry-leading solutions and a commitment to innovation continue to drive growth and unlock value. • Sales of $756 million, down 3% vs. prior year; Core sales increased 4% • GAAP diluted net EPS of $0.88; Adjusted diluted net EPS of $0.74 above prior guide of $0.68 to $0.72 • Operating cash flow was”
BILL BILL Holdings, Inc.

BILL Holdings, Inc. reported third fiscal quarter ended March 31, 2024 results: revenue $323.0 million, net income $31.8 million, EPS $0.30 and $0.00 per share, basic and diluted. Guidance reaffirmed.

“increased 19% year-over-year while non-GAAP operating income increased 68% year-over-year.” Financial Highlights for the Third Quarter of Fiscal 2024: • Total revenue was $323.0 million, an increase of 19% year-over-year. • Core revenue, which consists of subscription and transaction fees, was $281.3 million, an increase of 17% year-over-year. Subscription fees”
Elevation Oncology, Inc.

Elevation Oncology, Inc. reported financial results for the first quarter ended March 31, 2024.

“On May 2, 2024, Elevation Oncology, Inc. issued a press release announcing its financial results for the first quarter ended March 31, 2024.”
ONEW OneWater Marine Inc.

OneWater Marine Inc. reported fiscal second quarter ended March 31, 2024 results: revenue $488 million, net income $(5) million, or $(0.27) per diluted share, EPS $(0.27) per diluted share. Guidance reaffirmed.

“Inc. Announces Fiscal Second Quarter 2024 Results Maintaining previously issued fiscal full year 2024 outlook Fiscal Second Quarter 2024 Highlights • Revenue decreased 7% to $488 million • Same-store sales decreased 5% for the quarter; average annual increase of 4% over last two years • Gross profit margin of 24.6% • GAAP net loss of $(5) million, or $(0.27) per”
SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics, Inc. reported the quarter ended March 31, 2024 results: revenue $21.0 million, net income $87.4 million, EPS $1.18 per share.

“reference in such filing. --- EX-99.1 (EX-99.1) --- SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates – Achieved $21.0 million in OGSIVEO ® (nirogacestat) net product revenue in the first quarter – – Received validation from the EMA for MAA of nirogacestat for the treatment of adults with desmoid tumors”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.